The world is now entering its 9th month of combat against a pandemic of deadly pneumonia. Started out from China in December 2019, the disease has been declared as caused by infection with a so far unknown RNA Coronavirus of the respiratory family, then named severe acute respiratory syndrome coronavirus SARS-CoV-2. In the absence of a vaccine, and with scientists still struggling for an effective therapy, COVID-19 (the SARS-dependent syndrome) carries up to now, a death toll of more than 590,000 (July 18,2020) undermining jobs and finance of contemporary society in all continents. Social distancing, the only measure hitherto shown to restrain virus spread, has been progressively loosened from May 2020 in some countries, leaving us in the fear of repeat attacks from the unchecked virus. We discuss the problem and propose to tentatively boost the antivirus cell machinery by using lab-made viral mimics to engage cell receptors.

COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence

Ribaldone, Davide G;Fagoonee, Sharmila;Pellicano, Rinaldo
2021-01-01

Abstract

The world is now entering its 9th month of combat against a pandemic of deadly pneumonia. Started out from China in December 2019, the disease has been declared as caused by infection with a so far unknown RNA Coronavirus of the respiratory family, then named severe acute respiratory syndrome coronavirus SARS-CoV-2. In the absence of a vaccine, and with scientists still struggling for an effective therapy, COVID-19 (the SARS-dependent syndrome) carries up to now, a death toll of more than 590,000 (July 18,2020) undermining jobs and finance of contemporary society in all continents. Social distancing, the only measure hitherto shown to restrain virus spread, has been progressively loosened from May 2020 in some countries, leaving us in the fear of repeat attacks from the unchecked virus. We discuss the problem and propose to tentatively boost the antivirus cell machinery by using lab-made viral mimics to engage cell receptors.
2021
112
1
144
152
COVID-19; Carboxymethylcellulose Sodium; Cytokine Release Syndrome; Humans; Immunization, Passive; Interferon Inducers; Mucocutaneous Lymph Node Syndrome; Physical Distancing; Poly I-C; Polylysine; Practice Guidelines as Topic; RNA, Double-Stranded; RNA, Viral; Recurrence; Secondary Prevention; SARS-CoV-2
Actis, Giovanni C; Ribaldone, Davide G; Fagoonee, Sharmila; Pellicano, Rinaldo
File in questo prodotto:
File Dimensione Formato  
R10Y2021N01A0144.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 394.72 kB
Formato Adobe PDF
394.72 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1777998
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact